New hope for breast cancer survivors battling weight gain
NCT ID NCT07257484
Summary
This study is exploring whether a weekly medication called tirzepatide is a practical option for helping postmenopausal women who have survived hormone receptor-positive breast cancer and are living with obesity. Researchers want to see if participants can stick with the 6-month treatment and if it helps improve their weight, body composition, and certain health markers in their blood. The study involves 30 women who will have regular check-ins and tests to monitor their progress and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Weill Cornell Medicine
New York, New York, 10021, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.